Revision as of 13:01, 19 March 2011 edit86.92.236.252 (talk)No edit summary← Previous edit |
Latest revision as of 16:02, 21 November 2023 edit undo109.241.162.167 (talk) →Chemistry: Daltons → daltons, see Dalton (unit)#Unit name |
(31 intermediate revisions by 21 users not shown) |
Line 1: |
Line 1: |
|
|
{{short description|Pharmaceutical drug}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
⚫ |
| IUPAC_name = |
|
|
|
| Watchedfields = changed |
|
| image = Icodextrin skeletal.svg |
|
|
|
| verifiedrevid = 461936512 |
⚫ |
| synonyms = |
|
|
⚫ |
| IUPAC_name = |
⚫ |
| CAS_number = 337376-15-5 |
|
|
|
| image =Dextrin_skeletal.svg |
|
| CAS_supplemental = |
|
|
|
<!-- Clinical data --> |
⚫ |
| ATC_prefix = B05 |
|
|
|
| tradename = |
⚫ |
| ATC_suffix = DA |
|
|
|
| Drugs.com = {{drugs.com|international|icodextrin}} |
⚫ |
| ATC_supplemental = |
|
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
⚫ |
| PubChemSubstance = 17397419 |
|
|
⚫ |
| pregnancy_US = C |
⚫ |
| DrugBank = DB00702 |
|
|
| KEGG = D03266 |
|
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> |
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
⚫ |
| chemical_formula = (C<sub>6</sub>H<sub>10</sub>O<sub>5</sub>)<sub>n</sub> |
|
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
⚫ |
| molecular_weight = 13–19 ] |
|
|
| smiles = |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = Rx |
⚫ |
| bioavailability = 40% in 12 hours |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = ] |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = ] |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = C |
|
|
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = Rx |
|
|
| routes_of_administration = ] |
|
| routes_of_administration = ] |
|
|
<!-- Pharmacokinetic data --> |
|
⚫ |
| bioavailability = 40% in 12 hours |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = ] |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = ] |
|
|
<!-- Identifiers --> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
⚫ |
| CAS_number = 337376-15-5 |
|
⚫ |
| ATC_prefix = B05 |
|
⚫ |
| ATC_suffix = DA |
|
⚫ |
| ATC_supplemental = |
|
⚫ |
| PubChemSubstance = 17397419 |
|
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = DB00702 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = 2NX48Z0A9G |
|
|
| KEGG_Ref = {{keggcite|changed|kegg}} |
|
|
| KEGG = D03266 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 1201472 |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
|
| ChemSpiderID = none |
|
|
<!-- Chemical data --> |
|
⚫ |
| chemical_formula = (C<sub>6</sub>H<sub>10</sub>O<sub>5</sub>)<sub>n</sub> |
|
⚫ |
| molecular_weight = 13–19 kg/mol |
|
|
| smiles = |
|
⚫ |
| synonyms = |
|
}} |
|
}} |
|
|
|
|
|
'''Icodextrin''' (], ]) is a ] ] agent used in form of an ] solution for ] under the trade name '''Extraneal''',<ref name="RxList" /> and after gynecological ] surgery for the reduction of post-surgical ]s (fibrous bands that form between tissues and organs) under the trade name '''Adept'''.<ref name="FDA" /> |
|
'''Icodextrin''' (], ]) is a ] ] agent, derived from ],<ref name="maltod">{{cite book |title=Clinical evidence, Issue 14 |pages=1046 |author=American College of Physicians--American Society of Internal Medicine |year=2005 |publisher=BMJ Pub. Group}}</ref> used in form of an ] solution for ] under the trade name '''Extraneal''',<ref name="RxList" /> and after gynecological ] surgery for the reduction of post-surgical ]s (fibrous bands that form between tissues and organs) under the trade name '''Adept'''.<ref name="FDA" /> |
|
|
|
|
|
|
==Chemistry== |
|
==Physical and chemical properties== |
|
|
Icodextrin is a ]-derived, branched, water-soluble ] ] linked by α-(1→4) and less than 10% α-(1→6) ]s, making it a type of ]. Its weight-average molecular weight is between 13,000 and 19,000 ]s and its number-average molecular weight between 5,000 and 6,500 Daltons. The substance is a white to off-white solid, and the solution is clear and colourless to pale yellow.<ref name="FDA" /> |
|
Icodextrin is a ]-derived, branched, water-soluble ] ] linked by α-(1→4) and less than 10% α-(1→6) ]s, making it a type of ]. Its weight-average molecular weight is between 13,000 and 19,000 ]s and its number-average molecular weight between 5,000 and 6,500 daltons. The substance is a white to off-white solid, and the solution is clear and colourless to pale yellow.<ref name="FDA" /> |
|
|
|
|
|
==Mechanism of action== |
|
==Mechanism of action== |
Line 38: |
Line 56: |
|
|
|
|
|
]]] |
|
]]] |
|
When used for peritoneal dialysis, the icodextrin solution absorbs waste products from the blood, and is removed from the peritoneum after a few hours together with the waste.<ref>{{pmid|12962523}}</ref> |
|
When used for peritoneal dialysis, the icodextrin solution absorbs waste products from the blood, and is removed from the peritoneum after a few hours together with the waste.<ref>{{cite journal | vauthors = Frampton JE, Plosker GL | title = Icodextrin: a review of its use in peritoneal dialysis | journal = Drugs | volume = 63 | issue = 19 | pages = 2079–105 | year = 2003 | pmid = 12962523 | doi = 10.2165/00003495-200363190-00011 }}</ref> |
|
|
|
|
|
==Pharmacokinetics== |
|
==Pharmacokinetics== |
|
Icodextrin is not significantly metabolised inside the peritoneum. Instead, it is absorbed slowly (40% after 12 hours) into the bloodstream via the ]s. There it is broken down into ]s by the enzyme ]. In patients with intact kidney function, both icodextrin and its fragments are excreted via the kidney by ].<ref name="RxList">RxList.com: </ref><ref name="FDA">FDA: </ref> |
|
Icodextrin is not significantly metabolised inside the peritoneum. Instead, it is absorbed slowly (40% after 12 hours) into the bloodstream via the ]s. There it is broken down into ]s by the enzyme ]. In patients with intact kidney function, both icodextrin and its fragments are excreted via the kidney by ].<ref name="RxList">{{cite web | work = RxList.com | url = http://www.rxlist.com/extraneal-drug.htm | title = Extraneal }}</ref><ref name="FDA">{{cite web | work = FDA | url = http://www.accessdata.fda.gov/cdrh_docs/pdf5/P050011c.pdf | title = Adept (4% Icodextrin) Adhesion Reduction Solution }}</ref> |
|
|
|
|
|
==Contraindications== |
|
==Contraindications== |
|
Icodextrin is contraindicated in patients with cornstarch allergy, ] or ] intolerance, ], or severe ].<ref name="Drugs.com">Drugs.com: </ref> |
|
Icodextrin is contraindicated in patients with cornstarch allergy, ] or ] intolerance, ], or severe ].<ref name="Drugs.com">{{cite web | work = Drugs.com | url = https://www.drugs.com/pro/extraneal.html | title = Extraneal }}</ref> |
|
|
|
|
|
==Adverse effects== |
|
==Adverse effects== |
|
Adverse effects include ], ], ] (high blood pressure), ]es, and headache. Of these side effects, only hypertension and rashes occurred significantly more often than under glucose solution; the other events seem to be related to peritoneal dialysis in general.<ref name="Drugs.com" /> |
|
Adverse effects include ], ], ] (high blood pressure), ]es, and headache. Of these side effects, only hypertension and rashes occurred significantly more often than under glucose solution; the other events seem to be related to peritoneal dialysis in general.<ref name="Drugs.com" /> |
|
|
|
|
|
==Interactions== |
|
== Interactions == |
|
|
|
|
Icodextrin can mimic increased ] levels, depending on the used testing system. Specifically, glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase (GDO) based tests can erroneously show high blood glucose in patients that have been treated with icodextrin.<ref name="Drugs.com" /> |
|
Icodextrin can mimic increased ] levels, depending on the used testing system. Specifically, glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase (GDO) based tests can erroneously show high blood glucose in patients that have been treated with icodextrin.<ref name="Drugs.com" /> |
|
|
|
|
|
==References== |
|
== References == |
|
{{reflist}} |
|
{{reflist}} |
|
|
|
|
|
|
{{Blood substitutes and perfusion solutions}} |
|
{{B03, B05, B06}} |
|
|
|
|
|
|
] |
|
] |